• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物质谱:一种支持基于结构和基于片段的药物发现的“ESI”方法。

Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.

机构信息

NovAliX Structural Biology, Bioparc, Boulevard Sebastien Brant, Illkirch 67400, France.

出版信息

Future Med Chem. 2010 Jan;2(1):35-50. doi: 10.4155/fmc.09.141.

DOI:10.4155/fmc.09.141
PMID:21426045
Abstract

The success of early drug-discovery programs depends on the adequate combination of complementary and orthogonal technologies allowing hit/lead compounds to be optimized and improve therapeutic activity. Among the available biophysical methods, native MS recently emerged as an efficient method for compound-binding screening. Native MS is a highly sensitive and accurate screening technique. This review provides a description of the general approach and an overview of the possible characterization of ligand-binding properties. How native MS supports structure- and fragment-based drug research will also be discussed, with examples from the literature and internal developments. Native MS shows strong potential for in-depth characterization of ligand-binding properties. It is also a reliable screening technique in drug-discovery processes.

摘要

早期药物发现计划的成功取决于互补和正交技术的充分结合,这些技术可使命中/先导化合物得到优化并提高治疗活性。在现有的生物物理方法中,天然 MS 最近成为一种用于化合物结合筛选的有效方法。天然 MS 是一种高度灵敏和准确的筛选技术。本文综述了一般方法,并概述了配体结合特性的可能表征。还将讨论天然 MS 如何支持基于结构和基于片段的药物研究,以及文献和内部开发的实例。天然 MS 具有深入表征配体结合特性的强大潜力。它也是药物发现过程中的可靠筛选技术。

相似文献

1
Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.天然产物质谱:一种支持基于结构和基于片段的药物发现的“ESI”方法。
Future Med Chem. 2010 Jan;2(1):35-50. doi: 10.4155/fmc.09.141.
2
Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes.电喷雾电离质谱在药物发现中的应用:非共价复合物的研究
Nat Rev Drug Discov. 2006 Jul;5(7):585-95. doi: 10.1038/nrd2083.
3
Efficiency of hit generation and structural characterization in fragment-based ligand discovery.基于片段的配体发现中命中生成和结构表征的效率。
Curr Opin Chem Biol. 2011 Aug;15(4):482-8. doi: 10.1016/j.cbpa.2011.06.008. Epub 2011 Jul 1.
4
Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.利用基于配体和蛋白质的核磁共振光谱法将片段结合剂推进至类先导化合物。
Methods Enzymol. 2011;493:469-85. doi: 10.1016/B978-0-12-381274-2.00018-2.
5
Electrospray-ionization mass spectrometry as a tool for fast screening of protein structural properties.电喷雾电离质谱作为快速筛选蛋白质结构特性的工具。
Biotechnol J. 2009 Jan;4(1):73-87. doi: 10.1002/biot.200800250.
6
Recent progress in fragment-based lead discovery.基于片段的先导化合物发现的最新进展。
Curr Opin Pharmacol. 2009 Oct;9(5):615-21. doi: 10.1016/j.coph.2009.04.009. Epub 2009 May 27.
7
Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.通过微型尺寸排阻色谱法/质谱法对药物研发化合物进行药物筛选。
Rapid Commun Mass Spectrom. 2002;16(2):85-91. doi: 10.1002/rcm.546.
8
Ligand specificity, privileged substructures and protein druggability from fragment-based screening.基于片段的筛选中的配体特异性、优势亚结构和蛋白质成药性。
Curr Opin Chem Biol. 2011 Aug;15(4):469-74. doi: 10.1016/j.cbpa.2011.02.020. Epub 2011 Mar 14.
9
Native Mass Spectrometry in Fragment-Based Drug Discovery.基于片段的药物发现中的质谱分析技术
Molecules. 2016 Jul 28;21(8):984. doi: 10.3390/molecules21080984.
10
Structure-guided fragment screening for lead discovery.用于先导化合物发现的结构导向片段筛选
Curr Opin Drug Discov Devel. 2004 Jul;7(4):404-10.

引用本文的文献

1
Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development.迈向将原生质谱作为当代药物开发推动因素的常规应用。
RSC Med Chem. 2025 Jul 30. doi: 10.1039/d5md00617a.
2
Differential scanning fluorimetry followed by microscale thermophoresis and/or isothermal titration calorimetry as an efficient tool for ligand screening.差示扫描荧光法结合微量热泳和/或等温滴定量热法作为一种高效的配体筛选工具。
Biophys Rev. 2025 Feb 13;17(1):199-223. doi: 10.1007/s12551-025-01280-3. eCollection 2025 Feb.
3
Fragment-based drug discovery campaigns guided by native mass spectrometry.
基于天然质谱的片段药物发现研究
RSC Med Chem. 2024 May 22;15(7):2270-2285. doi: 10.1039/d4md00273c. eCollection 2024 Jul 17.
4
Gas-phase stability and thermodynamics of ligand-bound, binary complexes of chloramphenicol acetyltransferase reveal negative cooperativity.配体结合的氯霉素乙酰转移酶二元复合物的气相稳定性和热力学揭示了负协同性。
Anal Bioanal Chem. 2023 Oct;415(25):6201-6212. doi: 10.1007/s00216-023-04891-5. Epub 2023 Aug 5.
5
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.基于片段的抗分枝杆菌药物发现:成功与挑战。
Int J Mol Sci. 2022 Sep 14;23(18):10669. doi: 10.3390/ijms231810669.
6
High-Throughput Native Mass Spectrometry Screening in Drug Discovery.药物发现中的高通量天然质谱筛选
Front Mol Biosci. 2022 Apr 14;9:837901. doi: 10.3389/fmolb.2022.837901. eCollection 2022.
7
Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method.利用基于天然 MS 的亲和筛选方法从草药提取物中高效发现 SARS-CoV-2 3CL 样蛋白酶的潜在抑制剂。
J Pharm Biomed Anal. 2022 Feb 5;209:114538. doi: 10.1016/j.jpba.2021.114538. Epub 2021 Dec 14.
8
High-Resolution Native Mass Spectrometry.高分辨本地产物质谱。
Chem Rev. 2022 Apr 27;122(8):7269-7326. doi: 10.1021/acs.chemrev.1c00212. Epub 2021 Aug 20.
9
The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID: Topical Innovations.手性在3D化学空间探索及基于命中识别的现代药物发现方法中的重要性日益凸显:热点创新
ACS Med Chem Lett. 2021 Jul 16;12(8):1220-1229. doi: 10.1021/acsmedchemlett.1c00251. eCollection 2021 Aug 12.
10
Top-Down and Bottom-Up Proteomics Methods to Study RNA Virus Biology.基于蛋白质组学的自上而下和自下而上方法研究 RNA 病毒生物学。
Viruses. 2021 Apr 13;13(4):668. doi: 10.3390/v13040668.